Dominica Willmann

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylases.

Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylases.

Journal: Archiv der Pharmazie

Published: June 04, 2024

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.

Journal: Cancers

Published: February 13, 2024

Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity.

Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity.

Journal: Nature communications

Published: July 03, 2023

KMT9 Controls Stemness and Growth of Colorectal Cancer.

KMT9 Controls Stemness and Growth of Colorectal Cancer.

Journal: Cancer research

Published: April 23, 2021

Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.

Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.

Journal: Chembiochem : a European journal of chemical biology

Published: March 04, 2020

Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells.

Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells.

Journal: International journal of cancer

Published: April 01, 2019

KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.

KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.

Journal: Nature structural & molecular biology

Published: November 22, 2018

Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.

Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.

Journal: European journal of medicinal chemistry

Published: October 25, 2017

The histone acetyltransferase inhibitor Nir regulates epidermis development.

The histone acetyltransferase inhibitor Nir regulates epidermis development.

Journal: Development (Cambridge, England)

Published: August 15, 2017

KDM4 Inhibition Targets Breast Cancer Stem-like Cells.

KDM4 Inhibition Targets Breast Cancer Stem-like Cells.

Journal: Cancer research

Published: June 22, 2017

Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells.

Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells.

Journal: Nature communications

Published: May 16, 2017

The histone code reader Spin1 controls skeletal muscle development.

The histone code reader Spin1 controls skeletal muscle development.

Journal: Cell death & disease

Published: May 04, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026